Sportradar stock rating maintained at Market Outperform by Citizens

Citizens reiterated a Market Outperform and $31 price target based on 15x 2027E EBITDA while Sportradar trades at $16.57 (near its 52-week low $15.72) with a PEG of 0.23 and a $5.2B market cap (LTM revenue €/USD equiv. $1.52B). Q4 revenue was €369m (in line with consensus; constant-currency ~+1.5% vs. estimates) and adjusted EBITDA was €89m, ~6% above consensus with margin expansion to 24%. The company expanded a multi-year Hard Rock Bet agreement (PGA TOUR and UFC data), launched Playradar to combine sportsbook and casino content, and saw other firms set PTs at $22 (Benchmark) and $24 (Wells Fargo) while Guggenheim reiterated a Buy.

Analysis

Market pricing looks to be discounting the optionality of cross-selling a wagering-grade data stack into adjacent gaming products and prediction markets; that optionality converts a signage-like revenue stream into a higher-ARPU SaaS cadence only if the company sustains low incremental costs per event and keeps churn under single digits. Operationally, the real margin lever is not top-line growth but event-level fixed-cost dilution (data collection, low-latency infrastructure) — every 10-15% increase in handled live events should flow ~200–500bps to adjusted EBITDA if current technology scales as advertised.

A key second-order competitive risk is rights renegotiation dynamics: leagues and federations are learning to monetize data aggressively, so a 1–2 year window exists where pricing power can flip from vendor to rights-holder, creating step-function margin compression. Conversely, exclusive official feeds and proprietary latency advantages create buyer lock-in for sportsbooks that value microseconds and integrity — that moat is real but fragile vs. in-house league builds or consolidated rivals.

Near-term catalysts (next 3–12 months) are cadence-driven: renewal outcomes with top-tier operators and sequential in-play handle trends; medium-term (12–36 months) value comes from demonstrated ARPU lift from bundled sportsbook+casino+prediction products. Tail risks that would reverse the thesis quickly are (1) a major league pulling exclusives, (2) regulatory blowups around prediction markets, or (3) a material rise in rights costs that outpaces handle growth. Monitor customer concentration, gross margin per event, and in-play take rates as high-signal KPIs.

Key Decisions for Investors

• Long SRAD equity exposure via a two-year call-spread to capture optionality while capping premium: buy 24-month LEAP calls and sell a higher strike to finance cost (target +60–100% if cross-sell ramps; downside capped to premium paid).
• Pair trade to isolate execution risk: go long SRAD and short GENI (equal notional) for 12–24 months — thesis wins if SRAD converts official-data optionality into higher ARPU and operational leverage; risk: systemic sportsbook deceleration hurts both (stop-loss at 25% adverse move).
• Event-driven short window (3–6 months): buy ahead of the next earnings if recent cadence shows margin improvement, take profits on a 30–50% upside; protect with a 20–25% trailing stop to avoid being caught on a rights-renegotiation miss.
• Hedge for downside: if holding a material long position, buy 9–12 month puts or a put spread to cap losses from a binary rights-loss/regulatory event — cost is small insurance relative to potential >40% downside from a major contract loss.